ERIN VAUGHAN: Open Payments
NPI 1386099315 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 54 payments from 15 companies in 2025. Trend: 2023 $1,584 · 2024 $1,752 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $201 |
| Amgen Inc. | 12 | $191 |
| AstraZeneca Pharmaceuticals LP | 10 | $151 |
| ABBVIE INC. | 5 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $74 |
| Exact Sciences Corporation | 3 | $60 |
| PFIZER INC. | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| Astellas Pharma US Inc | 2 | $32 |
| Radius Health, Inc. | 1 | $26 |
Products named: Ozempic, EVENITY, AIRSUPRA, OTEZLA, XIFAXAN, Wegovy, FARXIGA, QULIPTA.
Industry payments across TX — which companies pay providers there.
